Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Students can find numerous ways to make quick money. Implement these fast solutions to boost your finances.
16,865 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
TradingView remains a go-to hub for charting and market research as volatility persists into 2026. This review breaks...
Stocks climbed on Monday after weekend actions in the Middle East, extending a pattern investors have watched in seve...
In 2026, crypto YouTube viewership fell sharply even as big channels still boast large subscriber counts. The shift r...
Ripple unveils a day-one Open USD partnership as XRP hovers near $1, with RLUSD clearing regulatory hurdles and insti...
An upbeat analyst stance helped lift shares of the first watch restaurant group. This article breaks down the catalys...
Palantir CEO Alex Karp argues that token-based access to frontier AI models is eroding enterprise value. The remarks ...
Market cycles swing, and a growth-driven Vanguard ETF could capture momentum in the second half of 2026. Here’s how t...
Belgium has cut tariffs on a targeted set of goods, a move that aims to ease costs for manufacturers and shoppers ali...
ADA rebounded about 40% from a late-June trough, with Cardano showing signs life as investors digest a major upgrade ...
As July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
The Dow’s first-half drama centered on one tech mega-cap that stood out for all the wrong reasons. This article break...